- Home
- CNTB vs LOAN Comparison
CNTB vs LOAN Comparison
Compare CNTB & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- LOAN
- Stock Information
- Founded
- CNTB 2012
- LOAN 1989
- Country
- CNTB United States
- LOAN United States
- Employees
- CNTB N/A
- LOAN N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- LOAN Real Estate Investment Trusts
- Sector
- CNTB Health Care
- LOAN Real Estate
- Exchange
- CNTB Nasdaq
- LOAN Nasdaq
- Market Cap
- CNTB 55.2M
- LOAN 65.8M
- IPO Year
- CNTB 2021
- LOAN 1999
- Fundamental
- Price
- CNTB $0.57
- LOAN $5.95
- Analyst Decision
- CNTB Strong Buy
- LOAN
- Analyst Count
- CNTB 1
- LOAN 0
- Target Price
- CNTB $8.00
- LOAN N/A
- AVG Volume (30 Days)
- CNTB 50.6K
- LOAN 15.0K
- Earning Date
- CNTB 03-31-2025
- LOAN 03-12-2025
- Dividend Yield
- CNTB N/A
- LOAN 7.73%
- EPS Growth
- CNTB N/A
- LOAN 2.37
- EPS
- CNTB N/A
- LOAN 0.49
- Revenue
- CNTB $26,033,000.00
- LOAN $7,351,609.00
- Revenue This Year
- CNTB $997.61
- LOAN N/A
- Revenue Next Year
- CNTB N/A
- LOAN N/A
- P/E Ratio
- CNTB N/A
- LOAN $12.17
- Revenue Growth
- CNTB N/A
- LOAN 1.12
- 52 Week Low
- CNTB $0.55
- LOAN $4.89
- 52 Week High
- CNTB $2.66
- LOAN $6.00
- Technical
- Relative Strength Index (RSI)
- CNTB 26.20
- LOAN 68.03
- Support Level
- CNTB $0.80
- LOAN $5.78
- Resistance Level
- CNTB $0.84
- LOAN $6.00
- Average True Range (ATR)
- CNTB 0.08
- LOAN 0.10
- MACD
- CNTB -0.02
- LOAN 0.03
- Stochastic Oscillator
- CNTB 6.34
- LOAN 88.89
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.